Healthy Male and Female Subjects

2
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alvotech
AlvotechLUXEMBOURG, Luxembourg
1 program
1
AVT80Phase 11 trial
Active Trials
NCT06732804Completed385Est. Jan 2026
Bristol Myers Squibb
1 program
1
DapagliflozinPhase 1Small Molecule

Trial Timeline

Clinical trial activity over time

2025
2026
AlvotechAVT80

Clinical Trials (1)

Total enrollment: 385 patients across 1 trials

Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio

Start: Feb 2025Est. completion: Jan 2026385 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space